Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1988 Feb;63(2):233–239.

MHC-unrestricted T-cell cytotoxicity against tumour cells.

A M Sponaas 1, B Loveland 1, E Simpson 1
PMCID: PMC1454511  PMID: 3258274

Abstract

F9 embryonal carcinoma cells (EC) grow as tumours in their strain of origin, 129/Sv, but can be rejected by mouse strains differing at the H-2 and/or non-H-2 loci. The presence of H-2 class I and/or minor H antigens on F9 and other EC cells is implied by (i) the rejection of EC cells by mice immunized with appropriate H-2 class I transfectants, and (ii) the ability of appropriate EC cells to prime mice for second-set in vivo skin-graft rejection responses to H-Y, and secondary MLC responses to multiple minor H antigens. However, EC cells express no H-2 class I antigens in vitro, and for in vivo rejection by T-cell responses directed either at allogeneic class I molecules or at minor H antigens restricted by self class I molecules, one would need to postulate that EC cells growing in vivo could express sufficient class I antigens for recognition by T cells. In the course of investigating this question, we found evidence for class I expression but also evidence for an additional antigen(s), shared by EC and tumour cells and recognized in a non-MHC-restricted manner.

Full text

PDF
233

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Artzt K., Jacob F. Letter: Absence of serologically detectable H-2 on primitive teratocarcinoma cells in culture. Transplantation. 1974 Jun;17(6):632–634. doi: 10.1097/00007890-197406000-00015. [DOI] [PubMed] [Google Scholar]
  2. Bell S. M., Stern P. L. Rat natural killer cell and cytotoxic T cell lysis of H-2-negative murine embryonal carcinoma cells. Eur J Immunol. 1985 Jan;15(1):59–65. doi: 10.1002/eji.1830150112. [DOI] [PubMed] [Google Scholar]
  3. Berstine E. G., Hooper M. L., Grandchamp S., Ephrussi B. Alkaline phosphatase activity in mouse teratoma. Proc Natl Acad Sci U S A. 1973 Dec;70(12):3899–3903. doi: 10.1073/pnas.70.12.3899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bradley A., Evans M., Kaufman M. H., Robertson E. Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature. 1984 May 17;309(5965):255–256. doi: 10.1038/309255a0. [DOI] [PubMed] [Google Scholar]
  5. Cartman G., Gallily R. Lysis of primitive teratocarcinoma cells by non-activated macrophages. Immunol Lett. 1985;10(3-4):207–211. doi: 10.1016/0165-2478(85)90079-3. [DOI] [PubMed] [Google Scholar]
  6. Cobbold S. P., Jayasuriya A., Nash A., Prospero T. D., Waldmann H. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature. 1984 Dec 6;312(5994):548–551. doi: 10.1038/312548a0. [DOI] [PubMed] [Google Scholar]
  7. Czitrom A. A., Gascoigne N. R. I. Characterization of cytotoxic effector cells generated from regional lymph nodes after immunization in the footpad. Immunology. 1983 Sep;50(1):121–129. [PMC free article] [PubMed] [Google Scholar]
  8. Dialynas D. P., Loken M. R., Glasebrook A. L., Fitch F. W. Lyt-2-/Lyt 3- variants of a cloned cytolytic T cell line lack an antigen receptor functional in cytolysis. J Exp Med. 1981 Mar 1;153(3):595–604. doi: 10.1084/jem.153.3.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Evans M. J., Kaufman M. H. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981 Jul 9;292(5819):154–156. doi: 10.1038/292154a0. [DOI] [PubMed] [Google Scholar]
  10. Forman J., Vitetta E. S. Absence of H-2 antigens capable of reacting with cytotoxic T cells on a teratoma line expressing a T/t locus antigen. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3661–3665. doi: 10.1073/pnas.72.9.3661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Galfrè G., Milstein C., Wright B. Rat x rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG. Nature. 1979 Jan 11;277(5692):131–133. doi: 10.1038/277131a0. [DOI] [PubMed] [Google Scholar]
  12. Hood L., Steinmetz M., Malissen B. Genes of the major histocompatibility complex of the mouse. Annu Rev Immunol. 1983;1:529–568. doi: 10.1146/annurev.iy.01.040183.002525. [DOI] [PubMed] [Google Scholar]
  13. Jakob H., Boon T., Gaillard J., Nicolas J., Jacob F. Tératocarcinome de la spuris: isolement, culture et propriétés de cellules a potentialités multiples. Ann Microbiol (Paris) 1973 Oct;124(3):269–282. [PubMed] [Google Scholar]
  14. Johnson L. L., Dove W. F. Male-specific transplantation antigen expression by XY teratocarcinomas PCC7 and 7'. Immunogenetics. 1984;19(3):233–241. doi: 10.1007/BF00364766. [DOI] [PubMed] [Google Scholar]
  15. Klein J., Figueroa F., David C. S. H-2 haplotypes, genes and antigens: second listing. II. The H-2 complex. Immunogenetics. 1983;17(6):553–596. doi: 10.1007/BF00366126. [DOI] [PubMed] [Google Scholar]
  16. Lindahl K. F., Langhorne J. Medial histocompatibility antigens. Scand J Immunol. 1981 Dec;14(6):643–654. doi: 10.1111/j.1365-3083.1981.tb00607.x. [DOI] [PubMed] [Google Scholar]
  17. Lynch D. H., Daynes R. A., Hodes R. J. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype. J Immunol. 1986 Feb 15;136(4):1521–1527. [PubMed] [Google Scholar]
  18. McBurney M. W., Rogers B. J. Isolation of male embryonal carcinoma cells and their chromosome replication patterns. Dev Biol. 1982 Feb;89(2):503–508. doi: 10.1016/0012-1606(82)90338-4. [DOI] [PubMed] [Google Scholar]
  19. Morello D., Daniel F., Baldacci P., Cayre Y., Gachelin G., Kourilsky P. Absence of significant H-2 and beta 2-microglobulin mRNA expression by mouse embryonal carcinoma cells. Nature. 1982 Mar 18;296(5854):260–262. doi: 10.1038/296260a0. [DOI] [PubMed] [Google Scholar]
  20. Moser A. R., Johnson L. L., Dove W. F. Mice coisogenically immunized against H-2 class I antigens on transfected L cells reject transplanted embryonal carcinoma cells. Immunogenetics. 1985;22(6):533–541. doi: 10.1007/BF00430301. [DOI] [PubMed] [Google Scholar]
  21. Moser A. R., Shedlovsky A., Johnson L. L. H-2 class I and Gt (H-2) antigens are identical: evidence from H-2 mutant mice. Immunogenetics. 1986;23(4):271–273. doi: 10.1007/BF00373023. [DOI] [PubMed] [Google Scholar]
  22. Robertson E. J., Evans M. J., Kaufman M. H. X-chromosome instability in pluripotential stem cell lines derived from parthenogenetic embryos. J Embryol Exp Morphol. 1983 Apr;74:297–309. [PubMed] [Google Scholar]
  23. Robinson P. J. Qb-1, a new class I polypeptide encoded by the Qa region of the mouse H-2 complex. Immunogenetics. 1985;22(3):285–289. doi: 10.1007/BF00404488. [DOI] [PubMed] [Google Scholar]
  24. Simmler M. C., Avner P. R. Differential Hm antigen expression on EC cells and early differentiated derivatives. EMBO J. 1985 May;4(5):1177–1185. doi: 10.1002/j.1460-2075.1985.tb03757.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Simmler M. C., Avner P., Levy J. P. Minor histocompatibility antigen expression on F9 embryonal carcinoma cells revealed by T-cell mediated responses. Immunogenetics. 1982;16(4):349–354. doi: 10.1007/BF00372306. [DOI] [PubMed] [Google Scholar]
  26. Simpson E., Gordon R., Taylor M., Mertin J., Chandler P. Micromethods for induction and assay of mouse mixed lymphocyte reactions and cytotoxicity. Eur J Immunol. 1976 Jul;5(7):451–455. doi: 10.1002/eji.1830050705. [DOI] [PubMed] [Google Scholar]
  27. Solter D., Knowles B. B. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci U S A. 1978 Nov;75(11):5565–5569. doi: 10.1073/pnas.75.11.5565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Stern P. L., Willison K. R., Lennox E., Galfrè G., Milstein C., Secher D., Ziegler A. Monoclonal antibodies as probes for differentiation and tumor-associated antigens: a Forssman specificity on teratocarcinoma stem cells. Cell. 1978 Aug;14(4):775–783. doi: 10.1016/0092-8674(78)90333-1. [DOI] [PubMed] [Google Scholar]
  29. Stern P., Gidlund M., Kimura A., Grönvik K. O., Wigzell H. Murine embryonal carcinoma cells: universal targets for mammalian NK cells? Int J Cancer. 1981 May 15;27(5):679–688. doi: 10.1002/ijc.2910270515. [DOI] [PubMed] [Google Scholar]
  30. Ware L. M., Axelrad A. A. Inherited resistance to N- and B-tropic murine leukemia viruses in vitro: evidence that congenic mouse strains SIM and SIM.R differ at the Fv-1 locus. Virology. 1972 Nov;50(2):339–348. doi: 10.1016/0042-6822(72)90385-6. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES